Status:
COMPLETED
Bone Properties in Hypoparathyroidism: Effects of PTH
Lead Sponsor:
John P. Bilezikian
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Hypoparathyroidism
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Whereas much information is known about the properties of bone in primary hyperparathyroidism, a disorder of parathyroid hormone (PTH) excess, virtually nothing is known about the skeleton in hypopara...
Detailed Description
A detailed description of the methods used in this study include the following: direct analysis of bone itself. skeletal dynamics and structure such as dual energy X-ray absorptiometry, quantitative c...
Eligibility Criteria
Inclusion
- Hypoparathyroidism
Exclusion
- Bisphosphonate use
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00473265
Start Date
May 1 2004
End Date
June 1 2014
Last Update
July 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032